TransCode Therapeutics, Inc. (RNAZ)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Nov 05, 16:00
TransCode Therapeutics Net Income (Quarterly) : -6.750M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.750M |
| March 31, 2026 | -17.79M |
| December 31, 2025 | -13.44M |
| September 30, 2025 | -4.856M |
| June 30, 2025 | -4.276M |
| March 31, 2025 | -12.09M |
| December 31, 2024 | -5.916M |
| September 30, 2024 | -2.321M |
| June 30, 2024 | -5.191M |
| March 31, 2024 | -3.327M |
| December 31, 2023 | -4.088M |
| September 30, 2023 | -5.30M |
| June 30, 2023 | -4.342M |
| March 31, 2023 | -4.817M |
| Date | Value |
|---|---|
| December 31, 2022 | -5.134M |
| September 30, 2022 | -4.290M |
| June 30, 2022 | -4.671M |
| March 31, 2022 | -3.470M |
| December 31, 2021 | -2.799M |
| September 30, 2021 | -2.330M |
| June 30, 2021 | 2.771M |
| March 31, 2021 | -4.485M |
| December 31, 2020 | -0.8015M |
| September 30, 2020 | -1.374M |
| June 30, 2020 | -0.1272M |
| March 31, 2020 | -0.0413M |
| December 31, 2019 | -0.1956M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 6.750M |
| EPS Diluted (Quarterly) | -7.172 |
| Enterprise Value | 159.85M |
| Earnings Yield | -3.36K% |
| Normalized Earnings Yield | -2470.46 |